Tempest Therapeutics Inc • TPST

Capital at risk.

About Tempest Therapeutics Inc
Ticker
info
TPST
Trading on
info
NASDAQ
ISIN
info
US87978U1088
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Stephen R. Brady J.D., LLM
Headquarters
info
2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
Employees
info
21
Website
info
tempesttx.com
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Metrics
BasicAdvanced
Market cap
info
$44.5M
P/E ratio
info
-
EPS
info
-$14.52
Dividend Yield
info
0.00%
Beta
info
-2.31
Forward P/E ratio
info
0
EBIDTA
info
$-43.1M
Ex dividend date
info
-
Price & volume
Market cap
info
$44.5M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
4.89
Earnings
EPS
info
-$14.52
EPS estimate (current quarter)
info
-$3.23
EPS estimate (next quarter)
info
-$2.59
EBITDA
info
$-43.1M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-2.31
52-week High
info
$15.08
52-week Low
info
$5.35
50-day moving average
info
$10.41
200-day moving average
info
$9.07
Short ratio
info
3.37
Short %
info
3.61%
Management effectiveness
ROE (TTM)
info
-322.57%
ROA (TTM)
info
-81.34%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
4.4M
Float
info
3.9M
Insiders %
info
0.11%
Institutions %
info
18.99%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$9.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.41
-$0.36
-13.89%
Q3 • 24Missed
-$0.31
-$0.25
-26.53%
Q4 • 24Missed
-$3.16
-$3.29
4.05%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0.5M
$-10.9M
-2,234.57%
Q1 • 25
$0M
$-7.9M
-∞%
Q2 • 25
-100.00%
-27.53%
∞%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$32.2M
$21M
65.39%
Q1 • 25
$24.5M
$14.7M
60.04%
Q2 • 25
-23.88%
-30.10%
-8.17%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-8M
$0M
$-0.7M
$-8M
Q1 • 25
$-8.4M
$0M
$1.2M
$8M
Q2 • 25
4.92%
-
-266.44%
-200.00%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Tempest Therapeutics Inc share?
Collapse

Tempest Therapeutics Inc shares are currently traded for undefined per share.

How many shares does Tempest Therapeutics Inc have?
Collapse

Tempest Therapeutics Inc currently has 4.4M shares.

Does Tempest Therapeutics Inc pay dividends?
Collapse

No, Tempest Therapeutics Inc doesn't pay dividends.

What is Tempest Therapeutics Inc 52 week high?
Collapse

Tempest Therapeutics Inc 52 week high is $15.08.

What is Tempest Therapeutics Inc 52 week low?
Collapse

Tempest Therapeutics Inc 52 week low is $5.35.

What is the 200-day moving average of Tempest Therapeutics Inc?
Collapse

Tempest Therapeutics Inc 200-day moving average is $9.07.

Who is Tempest Therapeutics Inc CEO?
Collapse

The CEO of Tempest Therapeutics Inc is Stephen R. Brady J.D., LLM.

How many employees Tempest Therapeutics Inc has?
Collapse

Tempest Therapeutics Inc has 21 employees.

What is the market cap of Tempest Therapeutics Inc?
Collapse

The market cap of Tempest Therapeutics Inc is $44.5M.

What is the P/E of Tempest Therapeutics Inc?
Collapse

The current P/E of Tempest Therapeutics Inc is null.

What is the EPS of Tempest Therapeutics Inc?
Collapse

The EPS of Tempest Therapeutics Inc is -$14.52.

What is the PEG Ratio of Tempest Therapeutics Inc?
Collapse

The PEG Ratio of Tempest Therapeutics Inc is null.

What do analysts say about Tempest Therapeutics Inc?
Collapse

According to the analysts Tempest Therapeutics Inc is considered a hold.